New patent for Otsuka drug REXULTI
Annual Drug Patent Expirations for REXULTI Rexulti is a drug marketed by Otsuka and is included in one NDA. It is available from two suppliers. There are six patents protecting…
Source
Annual Drug Patent Expirations for REXULTI Rexulti is a drug marketed by Otsuka and is included in one NDA. It is available from two suppliers. There are six patents protecting…
Source
Annual Drug Patent Expirations for NYMALIZE Nymalize is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are six patents protecting…
Source
This chart shows the drugs with the most patents in Hong Kong. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
Source
Which pharmaceutical drugs have the most drug patents in Hong Kong? Read Post »
Annual Drug Patent Expirations for ALIQOPA Aliqopa is a drug marketed by Bayer Healthcare and is included in one NDA. It is available from one supplier. There are four patents…
Source
New patent expiration for Bayer Healthcare drug ALIQOPA Read Post »
Annual Drug Patent Expirations for ONGENTYS Ongentys is a drug marketed by Neurocrine and is included in one NDA. It is available from two suppliers. There are nine patents protecting…
Source
This chart shows the patent expirations for powder dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
Source
Annual Drug Patent Expirations for OMONTYS+PRESERVATIVE+FREE Omontys Preservative Free is a drug marketed by Takeda Pharms Usa and is included in one NDA. There are six patents protecting this drug.…
Source
New patent expiration for Takeda Pharms drug OMONTYS PRESERVATIVE FREE Read Post »
Annual Drug Patent Expirations for OMONTYS Omontys is a drug marketed by Takeda Pharms Usa and is included in one NDA. There are six patents protecting this drug. This drug…
Source
New patent expiration for Takeda Pharms drug OMONTYS Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Lithuania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
Source
Which pharmaceutical companies have the most SPCs in Lithuania? Read Post »
Annual Drug Patent Expirations for BALVERSA Balversa is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are six patents…
Source
Get new actionable insights and updates from BiotechBlog